Skip to main content
SP5007,641.16-0.87%DOW52,759.21-1.32%NASDAQ26,067.17-1.00%BTC$73,769.00+6.23%ETH$2,346.22+3.67%GOLD$4,570.20-0.03%OIL$86.28-0.63%
Smart Investors Daily
Sign InSign Up Free
RA

NASDAQ · RANI

Rani Therapeutics Holdings, Inc.

Healthcare · Biotechnology

$0.85

Down-$0.07 (-7.16%)

Updated Aug 21, 2026, 7:46 AM

SID Score

4.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
107.3M
P/E ratio
-1.81
Dividend yield
0.00%
52-week range
$0.61 – $1.41
Volume
769.62K
Avg. volume
18.16M

Price performance

RANI price history

1M range · 21 trading sessions · Daily adjusted prices

RANI closed at $0.85 after 21 trading sessions, down 4.38% for the selected period.

Last close
$0.85
Period change
-4.38%
Period low
$0.77
Period high
$0.92
Daily close
View OHLC price history
RANI OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 20, 2026$0.8615$0.8997$0.85$0.851769.62K
Aug 19, 2026$0.811$0.9275$0.8024$0.91661.36M
Aug 18, 2026$0.81$0.89$0.752$0.82542.63M
Aug 17, 2026$0.81$0.816$0.7751$0.7959469.36K
Aug 14, 2026$0.781$0.8199$0.7711$0.7961889.23K
Aug 13, 2026$0.81$0.8202$0.7752$0.7979374.01K
Aug 12, 2026$0.7741$0.8238$0.7741$0.8028539.08K
Aug 11, 2026$0.7782$0.8081$0.7701$0.785323.56K
Aug 10, 2026$0.8036$0.8036$0.7642$0.7769338.67K
Aug 7, 2026$0.7849$0.80$0.7822$0.792202.06K
Aug 6, 2026$0.7879$0.8136$0.7786$0.7811696.09K
Aug 5, 2026$0.82$0.8428$0.7701$0.78747.04K
Aug 4, 2026$0.8012$0.8634$0.7986$0.821.12M
Aug 3, 2026$0.7791$0.8322$0.779$0.8013618.19K
Jul 31, 2026$0.82$0.84$0.76$0.7741436.51K
Jul 30, 2026$0.8464$0.8594$0.8129$0.8203238.86K
Jul 29, 2026$0.81$0.87$0.7911$0.8439722.6K
Jul 28, 2026$0.79$0.8281$0.783$0.8193342.49K
Jul 27, 2026$0.821$0.8698$0.7797$0.8101839.16K
Jul 24, 2026$0.87$0.9451$0.8386$0.85091.44M
Jul 23, 2026$0.8741$0.8999$0.7744$0.891.44M

Latest RANI news

The latest Smart Investors Daily articles mentioning RANI.

Stock researchCompany · Overview

RANI research

Overview

Company profile and research snapshot.

Company profile

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$15.67
Implied upside
—
Analysts
—
RANI recent ratings
DateFirmRatingTarget
Aug 18, 2026Chardan CapitalBuy—
May 20, 2026Canaccord GenuityBuy—
Apr 1, 2026Canaccord GenuityBuy—
Mar 27, 2026HC Wainwright & Co.Buy—
Jan 9, 2026HC Wainwright & Co.Buy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 24, 2025

Rani Therapeutics to Participate in the Evercore Healthcare Conference

SAN JOSE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the company’s management team will participate in the upcoming Evercore Healthcare Conference. Details below: 8th Annual Evercore Healthcare ConferenceDate: Wednesday, December 3, 2025 at 8:45 am E.T.Location: Coral Gables, FLPresenter: Chief Executive

globenewswire.com · Nov 24, 2025

Rani Therapeutics to Participate in the Evercore Healthcare Conference

SAN JOSE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the company's management team will participate in the upcoming Evercore Healthcare Conference. Details below:

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By